Keywords: خط اول درمان; Renal cell carcinoma; Pazopanib; Real-world evidence; First-line therapy; Survival outcomes; Tolerability;
مقالات ISI خط اول درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خط اول درمان; Bayesian Markov model; Cost-effectiveness; First-line therapy; Immunotherapy; NSCLC; Pembrolizumab;
Keywords: خط اول درمان; Antibiotic resistance; First-line therapy; Guidelines; Helicobacter pylori; Internist; Management; Therapy;
Keywords: خط اول درمان; Tivozanib; Sorafenib; First-line therapy; Metastatic renal cell carcinoma;
Keywords: خط اول درمان; Bismuth-containing quadruple therapy; Chronic gastritis; First-line therapy; Helicobacter pylori; Omeprazole-based triple therapy;
Keywords: خط اول درمان; Erythropoietic stimulating agents; First-line therapy; Hypomethylating agents; Myelodysplastic syndromes; Somatic mutations;
Keywords: خط اول درمان; First-line therapy; Meta-analysis; Systemic therapy; Taxanes; Urothelial carcinoma;
Keywords: خط اول درمان; Helicobacter pylori; Infection; Clarithromycin; Fluoroquinolone; Efficacy; First-line therapy;
Keywords: خط اول درمان; Pemphigus vulgaris; Rituximab; Intravenous immunoglobulin; First-line therapy; Corticosteroids; Immunosuppressive agents contraindicated; Long-term follow-up
Keywords: خط اول درمان; First-line therapy; Meta-analysis; Systemic therapy; Taxanes; Urothelial carcinoma;
Keywords: خط اول درمان; Early tumour shrinkage; Colorectal cancer; Prognostic factor; Overall survival; First-line therapy;
Keywords: خط اول درمان; Combination chemotherapy; Adjuvant therapy; Targeted therapy; First-line therapy; Metastatic colorectal cancer; Systemic therapy; Optimal sequence;
Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial
Keywords: خط اول درمان; Colorectal cancer; Prognostic factors; Primary tumour location; RAS mutation; BRAF mutation; Bevacizumab; Overall survival; First-line therapy;
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer
Keywords: خط اول درمان; Cixutumumab; IMC-A12; First-line therapy; Pemetrexed; NSCLC;
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
Keywords: خط اول درمان; Combination; Epidermal growth factor receptor inhibitor; First-line therapy; Insulin-like growth factor-1 inhibitor; Tyrosine kinase inhibitor;
The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials
Keywords: خط اول درمان; Advanced colorectal cancer; Costs of drugs; First-line therapy; Randomized phase III trials; Targeted therapies;
Original StudyDifferences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Keywords: خط اول درمان; BRIGHT trial; EORTC QLQ-C30; First-line therapy; Patient-reported outcomes; Phase 3;
Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies
Keywords: خط اول درمان; Capecitabine; Chemotherapy; First-line therapy; Metastatic breast cancer; Vinolrebine;
Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.
Keywords: خط اول درمان; Non-small cell lung cancer; Cost effectiveness; Comparative effectiveness; Maintenance therapy; First-line therapy;
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort
Keywords: خط اول درمان; AIDS events; composite outcome; deaths; first-line therapy; immunological response; non-nucleoside reverse transcriptase inhibitors; ritonavir-boosted protease inhibitors; virological response;
Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
Keywords: خط اول درمان; Non-small cell lung cancer; Chemotherapy; First-line therapy; Oral vinorelbine; Cisplatin; Nitroglycerin
Keywords: خط اول درمان; cost-effectiveness; first-line therapy; major depressive disorder (MDD); remission; selective norepinephrine reuptake inhibitor (SNRI); selective serotonin reuptake inhibitor (SSRI)
A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer
Keywords: خط اول درمان; Pomalidomide; Chemotherapy; Extensive-stage small-cell lung cancer; Phase I trial; First-line therapy
Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials
Keywords: خط اول درمان; Body mass index; Weight; Obesity; Non–small-cell lung cancer; Advanced disease; First-line therapy; Phase III; Chemotherapy; Bevacizumab
Gefitinib Compared with Systemic Chemotherapy as First-line Treatment for Chemotherapy-naive Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of Randomised Controlled Trials
Keywords: خط اول درمان; First-line therapy; gefitinib; lung cancer;
Ablation as First-Line Therapy for Atrial Fibrillation
Keywords: خط اول درمان; Atrial fibrillation; Ablation; First-line therapy; Antiarrhythmic medications;
Recommendations for the optimal management of early and advanced urothelial carcinoma
Keywords: خط اول درمان; Urinary bladder cancer; Bladder carcinoma; Transitional cell carcinoma; Review literature; First-line therapy; Second-line therapy; Adjuvant; Neoadjuvant
Ablation as First-Line Therapy for Atrial Fibrillation
Keywords: خط اول درمان; Atrial fibrillation; Catheter ablation; First-line therapy;
A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
Keywords: خط اول درمان; Carboplatin; Docetaxel; First-line therapy; Non-small cell lung carcinoma; Nonsquamous; Pemetrexed
Prevalence and effectiveness of first-, second-, and third-line systemic therapy in a cohort of unselected patients with advanced non-small cell lung cancer
Keywords: خط اول درمان; Non-small-cell-lung cancer; First-line therapy; Second-line therapy; Third-line therapy; Response; Progression free survival; Overall survival
Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment
Keywords: خط اول درمان; Amoxicillin; Esomeprazole; First-line therapy; H. pylori infection; Moxifloxacin
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade®) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)
Keywords: خط اول درمان; Bortezomib; Proteasome inhibitor; Metastatic; Non-small cell lung cancer; First-line therapy; Phase II Study; Monotherapy
Every-day clinical practice in patients with advanced non-small-cell lung cancer
Keywords: خط اول درمان; Non-small-cell-lung cancer; First-line therapy; Second-line therapy; Third-line therapy; Systemic therapy; Radiotherapy; Observational study
Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer
Keywords: خط اول درمان; Pemetrexed; Carboplatin; Dose-escalation; First-line therapy; Maintenance therapy; NSCLC;
Pemetrexed in the treatment of advanced non-squamous lung cancer
Keywords: خط اول درمان; Pemetrexed; NSCLC; Non-squamous carcinoma; First-line therapy; Second-line therapy; Maintenance therapy; SCLC
EGFR Inhibitors as First-Line Therapy in Advanced Non-small Cell Lung Cancer
Keywords: خط اول درمان; EGFR TK Inhibitors; First-line Therapy; NSCLC
Prise en charge des cancers bronchiques non à petites cellules après docétaxel-cisplatine
Keywords: خط اول درمان; Cancer bronchique non à petites cellules; Traitement de première ligne; Docétaxel; Cisplatine; Traitement de deuxième ligne; Non-small cell lung carcinoma; First-line therapy; Docetaxel; Cisplatin; Second-line therapy;
Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769L
Keywords: خط اول درمان; Epidermal growth factor receptor (EGFR); Mutation; Non-small cell lung cancer (NSCLC); Gefitinib; Chemotherapy; First-line therapy
Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC)
Keywords: خط اول درمان; Non-small-cell lung cancer; Oxaliplatin; Docetaxel; Chemotherapy; First-line therapy; Advanced disease
Results of a Phase II Trial of Gemcitabine in Patients with Non-Small-Cell Lung Cancer and a Performance Status of 2
Keywords: خط اول درمان; Community-based study; First-line therapy; Myelotoxicity; Pneumonitis;
Emerging Trends in the Clinical Use of Bortezomib in Multiple Myeloma
Keywords: خط اول درمان; Combination therapy; First-line therapy; Impaired renal/hepatic function; Proteasome inhibitor; Sequential therapy;
Phase II trial of liposomal doxorubicin at 40 mg/m2 every 4 weeks in endometrial carcinoma: A Gynecologic Oncology Group Study
Keywords: خط اول درمان; First-line therapy; Disseminated endometrial carcinoma; Liposomal doxorubicin;
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen
Keywords: خط اول درمان; SCLC; Extensive disease; First-line therapy; Topotecan; Etoposide; Platinum-free regimen;
Continuous-Infusion Vinorelbine for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Phase I/II Study
Keywords: خط اول درمان; Dose-limiting toxicity; First-line therapy; Maximum tolerated dose; Mucositis; Neutropenia;
Current and Future Perspectives on Fulvestrant
Keywords: خط اول درمان; Anastrozole; Antiestrogen; First-line therapy; Hormonal therapy; Second-line therapy;
Capecitabine/Oxaliplatin, a Safe and Active First-Line Regimen for Older Patients Metastatic Colorectal Cancer: Post Hoc Analysis of a Large Phase II Study
Keywords: خط اول درمان; Dose modifications; First-line therapy; Fluoropyrimidines; Stomatitis;